Middle East and Africa High-Resolution Melting Analysis Market Size, Growth, Trends & Forecast (2026–2034)

The Middle East and Africa (MEA) high-resolution melting analysis market size was valued at USD 41.38 million in 2025, is estimated at USD 43.72 million in 2026, and is projected to scale up to USD 67.91 million by 2034, registering a compound annual growth rate (CAGR) of 5.66% during the forecast period from 2026 to 2034. Growth is primarily driven by the increasing prevalence of genetic disorders and infectious diseases, advancing molecular biology infrastructure, and rising public-private genomics investments across the region.

Key Executive Metrics (At-a-Glance)

2025 Base Valuation: USD 41.38 Million
2026 Current Valuation: USD 43.72 Million
2034 Forecast Valuation: USD 67.91 Million
Compound Annual Growth Rate (CAGR): 5.66% (2026–2034)
Dominant Product Segment: Reagents, Consumables, and Instruments
Dominant Application Segment: Mutation Discovery and SNP Genotyping
Dominant End-User Segment: Pharmaceutical & Biotechnology Companies and Research Laboratories
Regional Growth Leaders: Kingdom of Saudi Arabia (KSA), United Arab Emirates (UAE), and Israel.

Core Market Drivers

Rising Genetic & Infectious Disease Burden: Increasing demand for rapid mutation discovery, non-invasive prenatal testing, and polymorphism screening.
Genomics Sector Investments: Growing public and private sector funding directed toward molecular diagnostic capabilities and healthcare modernization.
Technological Advantages: Superior speed, cost-effectiveness, and precision of high-resolution melting over traditional genotyping methods.

Primary Market Restraints & Challenges

Low Awareness & Penetration: Limited technical expertise and restricted penetration of HRM technology across select developing areas in Africa and the Middle East.
Technological Discrepancies: Instrument standardization challenges and data analysis complexities associated with specialized melt curve software.

Middle East and Africa High-Resolution Melting Analysis Market Segmentation Breakdown

Segment Category	Key Offerings / Categories
By Product and Service	Instruments, Reagents and Consumables, Software, Services
By Application	Mutation Discovery, SNP Genotyping, Species Identification, Pathogen Identification, Epigenetics
By End User	Pharmaceutical & Biotechnology Companies, Research Laboratories & Academic Institutes, Hospitals, Diagnostic Centers
By Country	KSA, UAE, Israel, Rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, Rest of MEA

Major Industry Players Profiled

Key companies operating in the MEA high-resolution melting analysis market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, QIAGEN N.V., Agilent Technologies Inc., bioMérieux S.A., Illumina, Inc., Meridian Bioscience, Inc., Novacyt, Azura Genomics, Canon Biomedical, and PREMIER Biosoft.

Middle East and Africa High Resolution Melting Analysis Market Size

The Middle East and Africa high resolution melting analysis Market size was valued at USD 41.38 million in 2025 and is anticipated to reach USD 43.72 million in 2025 from USD 67.91 million by 2034, growing at a CAGR of 5.66% during the forecast period from 2026 to 2034.

Non-Invasive Prenatal Testing is used to identify mutations, genetic abnormalities, and polymorphisms. High-Resolution Melting Analysis is a branch of molecular biology that includes other techniques like genotyping.

During the High-Resolution Melting procedure, the amplified region, termed an amplicon, is precisely heated at about 50 ËšC to 95 ËšC. At this temperature, the amplicon touches its melting point, and the two strands of DNA are parted or melted apart. The splitting of these strands is noted and compared with that of a normal person. Abnormalities are identified in these DNA strands by this comparison, which yields mutations and other differences.

The growth of the Middle East and Africa High-Resolution Melting Analysis Market is mainly driven by the rising frequency of infectious diseases and genetic ailments, improving healthcare infrastructure, rising public-private investments in the genomics sector, and the upsurge in the number of the elderly population. The benefits offered by HRM over genotyping are also among the chief drivers of the market. Low awareness, technological discrepancies, and the low penetration of High-Resolution Melting Analysis technology are among the market growth constraints.

KEY MARKET PLAYERS

Companies in the Middle East & Africa High-Resolution Melting Analysis market include

Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories
QIAGEN N.V.
Agilent Technologies Inc.
bioMérieux S.A.
Illumina, Inc.
Meridian Bioscience, Inc.
Novacyt
Azura Genomics
Canon Biomedical
PREMIER Biosoft

MARKET SEGMENTATION

This research report on the MEA High-Resolution Melting Analysis Market has been segmented and sub-segmented into the following categories.

By Product and Service

Instruments
Reagents and Consumables
Software
Services

By Application

Mutation Discovery
SNP Genotyping
Species Identification
Pathogen Identification
Epigenetics

By End User

Pharmaceutical & Biotechnology Companies
Research Laboratories & Academic Institutes
Hospitals
Diagnostic Centers

By Country

KSA
UAE
Israel
rest of GCC countries
South Africa
Ethiopia
Kenya
Egypt
Sudan
rest of MEA

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Middle East and Africa High Resolution Melting Analysis Market Report